Clinical Trial Update: Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome [NA]

View source ↗

Summary

An investigator-initiated trial evaluated the efficacy and safety of LAENNEC (Human Placenta Hydrolysate) given via ultrasound-guided subacromial bursa injectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shoulder Impingement Syndrome

Drugs mentioned

• LAENNEC (Human placenta hydrolysate)

Snippet

Sponsor: Green Cross Wellbeing | Conditions: Shoulder Impingement Syndrome | NA | Status: COMPLETED